Skip to main content

Breadcrumb

  1. Home

Electronic Health Records: Electronic Health Records

Use of Iron Therapy for Pediatric Patients

  • Percentage of all pediatric (less than 18 years old) in-center hemodialysis, home hemodialysis, and peritoneal dialysis patients with hemoglobin less than 11.0 g/dL and in whom serum ferritin concentration was less than 100 ng/ml and TSAT less than 20% who received IV iron or were prescribed oral iron within the following three months.

    CBE ID
    1433

Vascular Access—Functional Arteriovenous Fistula (AVF) or AV Graft or Evaluation for Placement

  • Percentage of end stage renal disease (ESRD) patients aged 18 years and older receiving hemodialysis during the 12-month reporting period and on dialysis >90 days who:

    1. have a functional autogenous AVF (defined as two needles used or a single-needle device [NOT one needle used in a two-needle device]) (computed and reported separately);

    2. have a functional AV graft (computed and reported separately); or

    CBE ID
    0251

Venous Thromboembolism Patients Recieving Unfractionated Heparin with Dosages/Platelet Count Monitoring by Protocol or Nomogram

  • This measure assesses the number of patients diagnosed with confirmed venous thromboembolism (VTE) who received intravenous (IV) unfractionated heparin (UFH) therapy dosages AND had their platelet counts monitored using defined parameters such as a nomogram or protocol. This measure is part of a set of six prevention and treatment measures that address VTE (VTE-1: VTE Prophylaxis, VTE-2: ICU VTE Prophylaxis, VTE-3: VTE Patients with Anticoagulation Overlap Therapy, VTE-5: VTE Warfarin Therapy Discharge Instructions and VTE-6: Incidence of Potentially-Preventable VTE).

    CBE ID
    0374

Venouse Thromboembolism Patients with Antocoagulation Overlap Therapy

  • This measure assesses the number of patients diagnosed with confirmed VTE who received an overlap of Parenteral (intravenous [IV] or subcutaneous [subcu]) anticoagulation and warfarin therapy. For patients who received less than five days of overlap therapy, they should be discharged on both medications or have a Reason for Discontinuation of Parenteral Therapy.

    CBE ID
    0373

Ventilator Bundle

  • Percentage of intensive care unit patients on mechanical ventilation
    at time of survey for whom all five elements of the ventilator bundle are documented and in place. The ventilator bundle elements are:
    •Head of bed (HOB) elevation 30 degrees or greater (unless medically contraindicated)
    •Daily “”sedation interruption” and daily assessment of readiness to extubate •Peptic ulcer disease prophylaxis
    •Deep Venous Thrombosis prophylaxis
    •Daily oral care with Chlorhexidine

    CBE ID
    0302